CONFLICT OF INTEREST STATEMENT
Eisaku Miyauchi received personal fees from Taiho Pharmaceutical Co., Ltd. outside of the submitted work. Akira Inoue received personal fees from Daiichi Sankyo Co., Ltd. outside of the submitted work. Shunichi Sugawara received personal fees from Taiho Pharmaceutical Co., Ltd., Chugai Pharma, AstraZeneca, MSD, Bristol‐Myers Squibb, Ono Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Pfizer, Eli Lilly & Co., Novartis, Kyowa Kirin Co., Ltd., and Yakult Honsha Co., Ltd. outside of the submitted work. None of the remaining authors declare any conflicts of interest.